PharmiWeb.com - Global Pharma News & Resources

Medical comms - Press Releases

Date Title Company
28-Feb-2020 MSL Insights Management Platform Now Enables MSLs and MSL Teams to Manage Every Step of the Insight Cycle System Analytic
28-Feb-2020 AXON Gets Another Wellbeing Award Nod from Great Place to Work® UK AXON
28-Feb-2020 iOnctura announces first patient dosed in a phase I clinical study of its novel highly selective PI3Kδ inhibitor, IOA-244 for solid tumours iOnctura
28-Feb-2020 NEW RESEARCH REVEALS THE NEED FOR GREATER UNDERSTANDING OF EUROPEAN PHARMACEUTICAL MARKETS TO MAXIMISE DIGITAL STRATEGIES Bryter
28-Feb-2020 MR Solutions’ dry magnet MRI system for molecular imaging on display at EMIM 2020 MR Solutions’
28-Feb-2020 Kiadis Pharma announces FDA clearance of clinical study by The Ohio State University in R/R AML with off-the-shelf NK cells from universal donors Kiadis
25-Feb-2020 ImmunOs Therapeutics Selects ProBioGen for Development and Large-Scale Manufacturing Services ImmunOs Therapeutics
25-Feb-2020 Novo Seeds Portfolio Company IO Biotech Announces Positive Outcome of Interim Analysis of Phase 2 Trial in First Line Non-small Cell Lung Cancer Novo Holdings A/S
25-Feb-2020 Akili Announces Publication of AKL-T01 ADHD Pivotal Study Results in The Lancet Digital Health Akili
25-Feb-2020 Sanofi to create new industry leading European company to provide active pharmaceutical ingredients (API*) Sanofi
24-Feb-2020 Sanofi to create new industry leading European company to provide active pharmaceutical ingredients (API*) Sanofi
24-Feb-2020 Almirall and Paratek enter into a License Agreement for Seysara® in China Almirall
24-Feb-2020 Positive long-term data in retinal clinical trial ReNeuron Group plc
24-Feb-2020 ASLAN PHARMACEUTICALS TO PRESENT AT 9th ANNUAL SVB LEERINK GLOBAL HEALTHCARE CONFERENCE ASLAN Pharmaceuticals
24-Feb-2020 FDA approves Lundbeck’s Vyepti™ (eptinezumab-jjmr) – the first and only intravenous preventive treatment for migraine H. Lundbeck A/S
24-Feb-2020 Genmab Board of Directors Chairman to Step Down Genmab
24-Feb-2020 Kyowa Kirin Announces Approval of CRYSVITA® (burosumab) in Switzerland for the Treatment of Adults and Children with X-Linked Hypophosphatemia (XLH) Kyowa Kirin Co., Ltd
22-Feb-2020 Save your dates for Cardiac Surgery 2020 Congress in Edinburgh, Scotland. Allied Academies
21-Feb-2020 Exclusive interview with Pharma Microbiology Boston Conference Chair Lynne Ensor, speaks about Coronavirus SMi Group
21-Feb-2020 Exclusive Interview with Martin Everett, CSO, Antabio, ahead of the Superbugs & Superdrugs Conference SMi Group